21 related articles for article (PubMed ID: 2107714)
1. Magnetic resonance imaging of the central nervous system in children with a new nonionic gadolinium contrast agent--gadoteridol injection (ProHance).
Byrd SE; Darling CF; Wilczynski MA
J Natl Med Assoc; 1993 May; 85(5):361-6. PubMed ID: 8496990
[TBL] [Abstract][Full Text] [Related]
2. Safety assessment of gadopentetate dimeglumine in U.S. clinical trials.
Goldstein HA; Kashanian FK; Blumetti RF; Holyoak WL; Hugo FP; Blumenfield DM
Radiology; 1990 Jan; 174(1):17-23. PubMed ID: 2403679
[TBL] [Abstract][Full Text] [Related]
3. Safety aspects and pharmacokinetics of inhaled aerosolized gadolinium.
Berthezène Y; Mühler A; Lang P; Shames DM; Clément O; Rosenau W; Kuwatsuru R; Brasch RC
J Magn Reson Imaging; 1993; 3(1):125-30. PubMed ID: 8428078
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cardiovascular changes after administration of gadodiamide injection and gadopentetate dimeglumine in dogs.
Bøkenes J; Hustvedt SO; Refsum H
Acad Radiol; 1997 Mar; 4(3):204-9. PubMed ID: 9084778
[TBL] [Abstract][Full Text] [Related]
5. Neurotoxic effects of gadopentetate dimeglumine: behavioral disturbance and morphology after intracerebroventricular injection in rats.
Ray DE; Cavanagh JB; Nolan CC; Williams SC
AJNR Am J Neuroradiol; 1996 Feb; 17(2):365-73. PubMed ID: 8938312
[TBL] [Abstract][Full Text] [Related]
6. Effects of Gd-DTPA after osmotic BBB disruption in a rodent model: toxicity and MR findings.
Roman-Goldstein SM; Barnett PA; McCormick CI; Szumowski J; Shannon EM; Ramsey FL; Mass M; Neuwelt EA
J Comput Assist Tomogr; 1994; 18(5):731-6. PubMed ID: 8089321
[TBL] [Abstract][Full Text] [Related]
7. Development of contrast media for magnetic resonance imaging.
Goldstein HA; Wiggins JR; Kashanian F
Ann N Y Acad Sci; 1992 Mar; 649():322-31. PubMed ID: 1580503
[No Abstract] [Full Text] [Related]
8. Gadopentetate dimeglumine-enhanced MR imaging of the musculoskeletal system.
Beltran J; Chandnani V; McGhee RA; Kursunoglu-Brahme S
AJR Am J Roentgenol; 1991 Mar; 156(3):457-66. PubMed ID: 1899738
[TBL] [Abstract][Full Text] [Related]
9. The effect of Gd-dimeglumine on subcutaneous tissues: a study with rats.
McAlister WH; McAlister VI; Kissane JM
AJNR Am J Neuroradiol; 1990; 11(2):325-7. PubMed ID: 2107714
[TBL] [Abstract][Full Text] [Related]
10. Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent.
Harpur ES; Worah D; Hals PA; Holtz E; Furuhama K; Nomura H
Invest Radiol; 1993 Mar; 28 Suppl 1():S28-43. PubMed ID: 8486501
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
